Welch & Forbes’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-12,100
| Closed | -$402K | – | 343 |
|
|
2017
Q2 | $402K | Sell |
12,100
-230
| -2% | -$7.64K | 0.01% | 266 |
|
|
2017
Q1 | $396K | Sell |
12,330
-1,120
| -8% | -$36K | 0.01% | 265 |
|
|
2016
Q4 | $487K | Sell |
13,450
-2,225
| -14% | -$80.6K | 0.01% | 244 |
|
|
2016
Q3 | $722K | Sell |
15,675
-366
| -2% | -$16.9K | 0.03% | 182 |
|
|
2016
Q2 | $805K | Sell |
16,041
-2,100
| -12% | -$105K | 0.02% | 204 |
|
|
2016
Q1 | $970K | Buy |
18,141
+400
| +2% | +$21.4K | 0.03% | 196 |
|
|
2015
Q4 | $1.17M | Buy |
17,741
+834
| +5% | +$54.8K | 0.04% | 182 |
|
|
2015
Q3 | $954K | Sell |
16,907
-5,680
| -25% | -$321K | 0.03% | 199 |
|
|
2015
Q2 | $1.34M | Sell |
22,587
-1,300
| -5% | -$76.8K | 0.04% | 191 |
|
|
2015
Q1 | $1.49M | Sell |
23,887
-2,618
| -10% | -$163K | 0.04% | 187 |
|
|
2014
Q4 | $1.53M | Buy |
26,505
+200
| +0.8% | +$11.5K | 0.04% | 185 |
|
|
2014
Q3 | $1.41M | Sell |
26,305
-4,550
| -15% | -$244K | 0.04% | 196 |
|
|
2014
Q2 | $1.62M | Sell |
30,855
-2,450
| -7% | -$128K | 0.05% | 176 |
|
|
2014
Q1 | $1.76M | Sell |
33,305
-3,160
| -9% | -$167K | 0.06% | 174 |
|
|
2013
Q4 | $1.46M | Sell |
36,465
-46,751
| -56% | -$1.87M | 0.05% | 179 |
|
|
2013
Q3 | $3.14M | Sell |
83,216
-64,773
| -44% | -$2.45M | 0.11% | 134 |
|
|
2013
Q2 | $5.8M | Buy |
+147,989
| New | +$5.8M | 0.21% | 105 |
|